The Effects of Exenatide Once Weekly (EXQW) and Exenatide Twice a Day (EXBID) on Beta-Cell Function in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis

BACKGROUND: In patients with type 2 diabetes mellitus (T2DM) and poor glycemic control receiving metformin (MET), glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are recommended as the adjunctive therapy. However, there are only a few studies involving the comparative effects of exenatide twic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jie, Jin, Xinye, An, Ping, Yu, Songyan, Mu, Yiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854923/
https://www.ncbi.nlm.nih.gov/pubmed/31772945
http://dx.doi.org/10.1155/2019/8083417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854923/
https://www.ncbi.nlm.nih.gov/pubmed/31772945
http://dx.doi.org/10.1155/2019/8083417

Ejemplares similares